Metropolitan Life Insurance Company (MetLife)’s Cadre Holdings CDRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,034
Closed -$37.4K 394
2024
Q1
$37.4K Sell
1,034
-201
-16% -$7K ﹤0.01% 1551
2023
Q4
$40.6K Hold
1,235
﹤0.01% 1557
2023
Q3
$32.9K Hold
1,235
﹤0.01% 1630
2023
Q2
$26.9K Hold
1,235
﹤0.01% 1772
2023
Q1
$26.6K Hold
1,235
﹤0.01% 1738
2022
Q4
$24.9K Buy
1,235
+124
+11% +$3.2K ﹤0.01% 1894
2022
Q3
$26.7K Hold
1,111
﹤0.01% 1858
2022
Q2
$21.9K Buy
+1,111
New +$26.2K ﹤0.01% 2013

Other funds holding CDRE

Metropolitan Life Insurance Company (MetLife)'s CDRE Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Cadre Holdings (CDRE) in Q2 2024, closing a stake of 1,034 shares — an estimated $37.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CDRE in Q2 2022 and held it in 8 quarters. The position peaked at $40.6K in Q4 2023. 128 funds tracked by Wall St. Rank hold CDRE as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Cadre Holdings position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,034 Cadre Holdings shares in Q2 2024, an estimated $37.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Cadre Holdings in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Cadre Holdings position peaked at $40.6K in Q4 2023.
  • 128 funds tracked by Wall St. Rank held Cadre Holdings as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.